Tamgene Salamat Pars
Biotechnology-Research
Company Tagline
a Subsidiary of HITCO Holding
Industry Category
Business Keywords
Company Description
Tamgene Salamat Pars is a leading biotechnology research company dedicated to advancing healthcare through innovative solutions. As a subsidiary of HITCO Holding, Tamgene Salamat Pars focuses on the production of specialty biotechnological medicines, including Molecular Anti-Bodies (MAB), with a commitment to improving patient outcomes.
Established in 2019, Tamgene Salamat Pars envisions a prosperous future by offering effective treatment solutions within the context of biological advancements at fair and moderate prices. While rooted in Iran, Tamgene Salamat Pars plans to expand its reach by exporting products to neighboring countries, ensuring broader access to its cutting-edge medicines.
Tamgene Salamat Pars is dedicated to innovation and excellence in the biotechnology sector. We invite the management of Tamgene Salamat Pars to create a customized and exclusive company showcase and product listing on our platform, enhancing its visibility and commercial opportunities.
Key Personnel / Employees
Similar Companies
Other organizations in the same industry
AquiNovo, Ltd.
Biotechnology-ResearchInnovative feed additives for growing more fish with less feed
PolarisQB
Biotechnology-ResearchComputational Chemistry is Complex. Our winning formula is simple.
Minerva Imaging
Biotechnology-ResearchAccelerated & Efficient Drug Development
Alternative Company Names
This company is also known as